Stryker Co. (NYSE:SYK) Stock Holdings Increased by Empowered Funds LLC

Empowered Funds LLC increased its position in shares of Stryker Co. (NYSE:SYK) by 17.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,644 shares of the medical technology company’s stock after purchasing an additional 1,140 shares during the quarter. Empowered Funds LLC’s holdings in Stryker were worth $2,752,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of SYK. Kingsview Wealth Management LLC grew its position in shares of Stryker by 1.4% during the 4th quarter. Kingsview Wealth Management LLC now owns 14,318 shares of the medical technology company’s stock valued at $5,155,000 after buying an additional 200 shares during the last quarter. Conning Inc. boosted its stake in Stryker by 5.1% in the fourth quarter. Conning Inc. now owns 2,520 shares of the medical technology company’s stock valued at $907,000 after acquiring an additional 123 shares during the period. EULAV Asset Management boosted its stake in Stryker by 2.1% in the fourth quarter. EULAV Asset Management now owns 119,513 shares of the medical technology company’s stock valued at $43,031,000 after acquiring an additional 2,469 shares during the period. Appleton Partners Inc. MA grew its holdings in shares of Stryker by 5.0% during the fourth quarter. Appleton Partners Inc. MA now owns 29,222 shares of the medical technology company’s stock valued at $10,521,000 after purchasing an additional 1,400 shares during the last quarter. Finally, Bright Financial Advisors Inc. raised its position in shares of Stryker by 3.1% during the 4th quarter. Bright Financial Advisors Inc. now owns 17,591 shares of the medical technology company’s stock worth $6,334,000 after purchasing an additional 525 shares during the period. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of recent research reports. The Goldman Sachs Group upped their price objective on Stryker from $384.00 to $427.00 and gave the stock a “neutral” rating in a research note on Thursday, January 30th. Morgan Stanley upgraded shares of Stryker from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $370.00 to $445.00 in a research report on Monday, December 2nd. Piper Sandler reaffirmed an “overweight” rating and issued a $420.00 price objective (up previously from $380.00) on shares of Stryker in a report on Wednesday, October 30th. Royal Bank of Canada boosted their target price on shares of Stryker from $425.00 to $435.00 and gave the company an “outperform” rating in a research note on Wednesday, January 29th. Finally, Barclays raised their price target on shares of Stryker from $418.00 to $443.00 and gave the company an “overweight” rating in a research note on Monday. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, Stryker currently has an average rating of “Moderate Buy” and a consensus target price of $420.68.

Insider Activity

In other news, Director Ronda E. Stryker sold 201,392 shares of the business’s stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now directly owns 3,642,075 shares of the company’s stock, valued at $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 5.90% of the company’s stock.

Stryker Trading Up 0.7 %

Shares of SYK stock opened at $388.28 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The stock has a 50-day simple moving average of $377.19 and a 200 day simple moving average of $366.15. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The stock has a market capitalization of $148.02 billion, a P/E ratio of 50.04, a P/E/G ratio of 2.98 and a beta of 0.96.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter last year, the business posted $3.46 earnings per share. On average, sell-side analysts expect that Stryker Co. will post 13.49 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be issued a $0.84 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.87%. Stryker’s dividend payout ratio is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.